FI882921A0 - Protaminzink-insulinpreparat. - Google Patents

Protaminzink-insulinpreparat.

Info

Publication number
FI882921A0
FI882921A0 FI882921A FI882921A FI882921A0 FI 882921 A0 FI882921 A0 FI 882921A0 FI 882921 A FI882921 A FI 882921A FI 882921 A FI882921 A FI 882921A FI 882921 A0 FI882921 A0 FI 882921A0
Authority
FI
Finland
Prior art keywords
protaminzink
insulinpreparat
Prior art date
Application number
FI882921A
Other languages
English (en)
Other versions
FI882921A (fi
Inventor
Bent Skelbaek-Pedersen
Original Assignee
Novo Industri As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK503486A external-priority patent/DK503486D0/da
Priority claimed from DK575686A external-priority patent/DK575686D0/da
Application filed by Novo Industri As filed Critical Novo Industri As
Publication of FI882921A0 publication Critical patent/FI882921A0/fi
Publication of FI882921A publication Critical patent/FI882921A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI882921A 1986-10-20 1988-06-17 Protaminzink-insulinpreparat. FI882921A (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK503486A DK503486D0 (da) 1986-10-20 1986-10-20 Polypeptidpraeparater med god absorption
DK575686A DK575686D0 (da) 1986-12-01 1986-12-01 Forbedret produkt
PCT/DK1987/000126 WO1988002633A1 (en) 1986-10-20 1987-10-16 Protamine zinc insulin preparations

Publications (2)

Publication Number Publication Date
FI882921A0 true FI882921A0 (fi) 1988-06-17
FI882921A FI882921A (fi) 1988-06-17

Family

ID=26067701

Family Applications (1)

Application Number Title Priority Date Filing Date
FI882921A FI882921A (fi) 1986-10-20 1988-06-17 Protaminzink-insulinpreparat.

Country Status (6)

Country Link
EP (1) EP0265214A3 (fi)
JP (1) JPH01501389A (fi)
AU (1) AU8175387A (fi)
FI (1) FI882921A (fi)
PT (1) PT85950A (fi)
WO (1) WO1988002633A1 (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5130298A (en) * 1989-05-16 1992-07-14 Ethicon, Inc. Stabilized compositions containing epidermal growth factor
DK134691D0 (da) * 1991-07-12 1991-07-12 Novo Nordisk As Apparat
CA2072809C (en) * 1992-06-30 1998-05-19 Rudolf Gruber Seat adjuster with compensating link
EP2311436A1 (en) 1998-04-27 2011-04-20 Altus Pharmaceuticals Inc. Stabilized protein crystals, formulations containing them and methods of making them
BR9911678A (pt) * 1998-06-30 2001-03-20 Novo Nordisk As Cristais de semeadura para a preparação de peptìdeos ou preteìnas.
RU2205188C2 (ru) 1998-06-30 2003-05-27 Ново Нордиск А/С Затравочные кристаллы для получения пептидов или протеинов
DE19900792C1 (de) 1999-01-12 2000-06-15 Disetronic Licensing Ag Vorrichtung zur Verabreichung eines injizierbaren Produkts
DE19900827C1 (de) 1999-01-12 2000-08-17 Disetronic Licensing Ag Vorrichtung zur dosierten Verabreichung eines injizierbaren Produkts
EP1664398A4 (en) 2003-09-03 2009-08-26 Shmuel Bukshpan METHODS AND DEVICES FOR REALIZING RAPID CRYSTALLIZATION OF BIOLOGICAL MOLECULES
WO2017163159A1 (en) 2016-03-21 2017-09-28 Wockhardt Limited Biphasic pharmaceutical composition of insulin human

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK87403C (da) * 1953-06-04 1959-06-08 Novo Terapeutisk Labor As Fremgangsmåde til fremstilling af protraheret virkende, injicerbare insulinpræparater.
FR1282504A (fr) * 1954-06-03 1962-01-27 Novo Terapeutisk Labor As Procédé de production de suspensions stables d'insuline zinc-protamine
GB889769A (en) * 1957-07-18 1962-02-21 Nordisk Insulinlab Slowly acting insulin preparation in crystalline form
DE1126561B (de) * 1960-07-05 1962-03-29 Hoechst Ag Verfahren zur Herstellung von mikrokristallinem Insulin
US3868358A (en) * 1971-04-30 1975-02-25 Lilly Co Eli Protamine-insulin product
US3758683A (en) * 1971-04-30 1973-09-11 R Jackson Insulin product
CA1176158A (en) * 1981-08-27 1984-10-16 Ronald E. Chance Pharmaceutical formulations comprising human insulin and human c-peptide
DE3333640A1 (de) * 1983-09-17 1985-04-25 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von insulin-derivaten, deren b-kette c-terminal verlaengert ist, neue basisch modifizierte insulin-derivate diese enthaltende mittel und ihre verwendung

Also Published As

Publication number Publication date
EP0265214A2 (en) 1988-04-27
PT85950A (en) 1987-11-01
JPH01501389A (ja) 1989-05-18
FI882921A (fi) 1988-06-17
AU8175387A (en) 1988-05-06
WO1988002633A1 (en) 1988-04-21
EP0265214A3 (en) 1989-07-26

Similar Documents

Publication Publication Date Title
DE3774909D1 (de) Antitumormittel.
DE3775679D1 (de) Vernebler.
ATE57924T1 (de) 3-aryloxy-3-substituierte-propanamine.
ATE63533T1 (de) Xylolisomerisierung.
FI871003A0 (fi) Foervaringssystem.
DE3771918D1 (de) Chinolinamide.
DE3786679T2 (de) Schmitt-triggerschaltung.
DE3773636D1 (de) Saeurebeschleunigte hydrocarboxilierung.
FI860054A0 (fi) Motionsanordning.
FI864674A (fi) Ljusradiator.
FI865094A0 (fi) Planformig textilstruktur.
DE3779382D1 (de) 3-6-diphenylpyridazine.
FI873607A (fi) Vaermeisolerad roerledning.
FI882921A (fi) Protaminzink-insulinpreparat.
DE3763648D1 (de) Rollski.
FI860046A0 (fi) Foerlaengningsanordning foer traefaner.
DE3766410D1 (de) Methylalkylcyclosiloxane.
DE3669032D1 (de) Okulopressionsgeraet.
FI865029A0 (fi) Vaerme kaensliga registreringsmaterial.
DE3764485D1 (de) Polyglycidylamine.
FI860072A (fi) Mataranordning foer en spannmaolstork.
DE3781179T2 (de) Acyl-coa-synthetase.
FI851776L (fi) Elkandelaber.
FI77957B (fi) Taendnings- och matarkoppling foer lyslampor.
ATE48604T1 (de) Sulfidoxymolybden-dialkylphosphorodithioate.

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: NOVO INDUSTRI A/S